GlassScriptPhysician profile
Aaron M Winnick
NPI 1508031428
$764.19
in general payments reported to CMS, 2019-2025
11 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $52.37 · 2021: $241 · 2022: $106 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117 · Travel and Lodging: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.86 |
| Travel and Lodging | $111.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organox LTD | $159.37 | 2025 | |
| Angiodynamics, INC. | $135.45 | 2021 | |
| Integra Lifesciences Corporation | $89.44 | 2021-2022 | |
| Acell, INC. | $76.30 | 2019-2020 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $68.88 | 2025 | |
| Shire North American Group INC | $67.80 | 2019 | |
| Allergan, INC. | $58.57 | 2021-2022 | |
| Boston Scientific Corporation | $33.33 | 2022 | |
| Polynovo North America LLC | $30.73 | 2021 | |
| Olympus America INC. | $27.95 | 2019 | |
| Teleflex LLC | $16.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Winnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.